Home β€Ί Stock analysis β€Ί SNTI

Senti Biosciences (SNTI) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

SNTI slides 14.2% to $0.22, a 52-week low on 3.5x normal volume. Closed at $0.22, -14.16% vs the prior close of $0.26. Day range $0.21–$0.25, opened at $0.25.

Last close$0.22-14.16%
Day range0.21–0.25
Open0.25
Volume3.44M
52-week range0.21–2.88
Avg volume (20d)1.99M

SNTI daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” SNTI slides 14.2% to $0.22, a 52-week low on 3.5x normal volume
Oct 15, 2026 β€” SNTI jumps 8.7% to $0.26 on 28.3x normal volume
Oct 14, 2026 β€” SNTI slides 5.5% to $0.24, a 52-week low
Oct 13, 2026 β€” SNTI slides 20.1% to $0.25, a 52-week low
Oct 12, 2026 β€” SNTI rises 1.6% to $0.32
Oct 9, 2026 β€” SNTI dips 2.5% to $0.31
Oct 8, 2026 β€” SNTI dips 2.4% to $0.32
Oct 7, 2026 β€” SNTI rises 2.2% to $0.33
Oct 6, 2026 β€” SNTI slides 6.4% to $0.32
Oct 5, 2026 β€” SNTI jumps 7.1% to $0.34, a 1-month high
Oct 2, 2026 β€” SNTI dips 0.6% to $0.32

SNTI latest news & SEC filings

Every SEC filing by or about SNTI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 15, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001628280-26-065992

Oct 13, 2026 Β· Form DEFA14A β€” Additional proxy materials

Additional proxy materials

Source: SEC EDGAR filing 0001628280-26-065686

Oct 13, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001628280-26-065685

Sep 24, 2026 Β· Form EFFECT β€” EFFECT filing

EFFECT filing

Source: SEC EDGAR filing 9999999995-26-003050

Sep 24, 2026 Β· Form DEFM14A β€” DEFM14A filing

DEFM14A filing

Source: SEC EDGAR filing 0001140361-26-037574

Sep 24, 2026 Β· Form 424B3 β€” Prospectus / supplement for an offering or resale

Prospectus / supplement for an offering or resale

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001193125-26-401118

Sep 24, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001628280-26-063369

Sep 24, 2026 Β· Form PRER14A β€” PRER14A filing

PRER14A filing

Source: SEC EDGAR filing 0001140361-26-037470

Sep 22, 2026 Β· Form S-3/A β€” S-3/A filing

S-3/A filing

Source: SEC EDGAR filing 0001193125-26-397190

Sep 11, 2026 Β· Form SCHEDULE 13D/A β€” Update to a 13D 5%+ stake disclosure

Update to a 13D 5%+ stake disclosure

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0000902664-26-003795

Sep 10, 2026 Β· Form S-3/A β€” S-3/A filing

S-3/A filing

Source: SEC EDGAR filing 0001193125-26-388031

Sep 4, 2026 Β· Form PRER14A β€” PRER14A filing

PRER14A filing

Source: SEC EDGAR filing 0001140361-26-035672

Sep 4, 2026 Β· Form DEFA14A β€” Additional proxy materials

Additional proxy materials

Source: SEC EDGAR filing 0001628280-26-060602

Sep 4, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001628280-26-060600

Sep 2, 2026 Β· Form DEFA14A β€” Additional proxy materials

Additional proxy materials

Source: SEC EDGAR filing 0001628280-26-060129

Things to know before you trade SNTI

SNTI market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20260.250.250.210.223.44M
Oct 15, 20260.240.260.240.2618.99M
Oct 14, 20260.250.260.240.24166.30K
Oct 13, 20260.310.310.250.25302.80K
Oct 12, 20260.310.320.310.32142.70K
Oct 9, 20260.320.320.310.31109.90K
Oct 8, 20260.310.330.310.32247.20K
Oct 7, 20260.310.350.310.33330.70K
Oct 6, 20260.320.340.310.32204.00K
Oct 5, 20260.310.340.310.34378.30K
Oct 2, 20260.310.330.310.32124.60K
Oct 1, 20260.310.340.300.32613.20K
Sep 30, 20260.300.320.300.3183.60K
Sep 29, 20260.310.340.300.31291.80K
Sep 28, 20260.330.340.310.31549.00K
Sep 25, 20260.320.340.310.33920.50K
Sep 24, 20260.350.370.330.342.30M
Sep 23, 20260.330.360.320.3410.37M
Sep 22, 20260.310.340.310.32184.10K
Sep 21, 20260.320.320.310.31103.60K

About Senti Biosciences

Senti Biosciences (SNTI) is listed on the Nasdaq and classified by the SEC under β€œBiological Products, (No Diagnostic Substances)”. Its business address is in SOUTH SAN FRANCISCO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1854270.

SNTI board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Timothy K LuCEOMar 11, 2026

Executive officers

NameTitleLatest filing
Timothy K LuCEOMar 11, 2026
Kanya RajangamPres. & Chief Med. & Dev. Off.Mar 11, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

SNTI financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025$22.00K$-61.44M-2.73$-43.44M
Dec 31, 2024$0$-52.79M-12.03$-41.40M
Dec 31, 2023$1.98M$-71.06M-16.01$-52.40M
Dec 31, 2022$3.29M$-58.21M-2.23$-34.90M
Dec 31, 2021$2.29M$-55.32M-19.00$-34.63M

Latest balance sheet: total assets $33.10M, total liabilities $36.51M, cash $6.46M (as of Jun 30, 2026).

SNTI earnings / results-day log

DateFilingClose that day
Jul 15, 20268-K Item 2.02 (results)$0.58
May 14, 20268-K Item 2.02 (results)$1.04
Mar 27, 20268-K Item 2.02 (results)$0.79
Nov 13, 20258-K Item 2.02 (results)$1.79
Aug 7, 20258-K Item 2.02 (results)$1.54
May 6, 20258-K Item 2.02 (results)$3.30
Apr 28, 20258-K Item 2.02 (results)$3.64
Mar 20, 20258-K Item 2.02 (results)$3.51
Nov 14, 20248-K Item 2.02 (results)$2.33
Aug 13, 20248-K Item 2.02 (results)β€”
May 9, 20248-K Item 2.02 (results)β€”
Mar 21, 20248-K Item 2.02 (results)β€”

Related stocks Β· Biological Products, (No Diagnostic Substances)

Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on SNTI

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.